Conor Hanley has served as a member of our Board since 2025 and is also anticipated to be a member of our audit committee following the Annual Meeting. Mr. Hanley currently serves as the Chief Executive Officer of Foundry Innovation & Research 1, Ltd. ( FIRE1 ). Mr. Hanley brings nearly a decade of distinguished experience in the medical technology industry, with a proven track record of leadership and innovation. Since 2016, he has been an integral member of FIRE1 s executive team, where he has played a critical role in advancing the company s mission to revolutionize heart failure management. Mr. Hanley previously worked with ResMed Inc. ( ResMed ) where he held senior management positions including leading up Chronic Disease management solutions globally, the global Cardiology business unit and the Ventures and Initiatives global business unit for corporate investments and accelerating new business. Prior to ResMed, Conor was Chief Executive Officer and Co-Founder of BiancaMed, Inc., which was acquired by ResMed in 2011. Over 7 years, he led a team that grew the company through three rounds of venture funding from top-tier international venture funds, launching products in Japan and USA (selling major retailers, including the Apple store) and building the supply chain with mass production in China. Mr. Hanley was awarded a PhD in Chemical Engineering from the University of Pennsylvania, an MBA from INSEAD and a BEng from University College Dublin. Mr. Hanley completed the Leadership4Growth program at Stanford University and is qualified Chartered director from the Institute of Directors, UK. We believe that Mr. Hanley is qualified to serve on our Board due to his industry expertise, strategic vision, and commitment to patient-centered innovation.